Keros Therapeutics
KROS
#6988
Rank
ยฃ0.31 B
Marketcap
ยฃ7.86
Share price
0.65%
Change (1 day)
-84.30%
Change (1 year)

Keros Therapeutics (KROS) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.43 Billion

According to Keros Therapeutics's latest financial reports the company has ยฃ0.43 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Keros Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.44 B71.66%
2023-12-31ยฃ0.25 B12.69%
2022-12-31ยฃ0.23 B35.34%
2021-12-31ยฃ0.17 B-12.63%
2020-12-31ยฃ0.19 B3543.58%
2019-12-31ยฃ5.35 M-70.78%
2018-12-31ยฃ18.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.20 B-54.29%๐Ÿ‡บ๐Ÿ‡ธ USA